Skip to main content
. 2006 Jan;168(1):115–122. doi: 10.2353/ajpath.2006.050518

Table 1-6704.

Pancreatic SSAT Activities, Polyamine Pools, α-Amylase Activities, and Histology in Nontransgenic Rats after Treatment with l-Arginine or Cerulein with or without Pretreatment with MeSpd

Group (number of animals) SSAT (pmol/mg/10 minutes) Putrescine (pmol/mg tissue weight) Spermidine (pmol/mg tissue weight) Spermine (pmol/mg tissue weight) MeSpd (pmol/mg tissue weight) α -Amylase (U/L) Histology
Control (9) 3.6 ± 0.8 7 ± 9 4405 ± 1708 862 ± 364 1913 ± 462 Normal
l-arginine (8) 10.5 ± 6.4* 293 ± 340 2138 ± 1297 406 ± 170 20,785 ± 8681 Moderate to severe
l-arginine + 13.7 ± 7.0 492 ± 353* 3276 ± 1420 584 ± 183* 1669 ± 705 5221 ± 3838 Normal to mild
MeSpd (11)
Control (5) 4.4 ± 1.6 32 ± 3 4100 ± 320 750 ± 260 2650 ± 210 Normal
Cerulein (6) 31.9 ± 4.7 185 ± 47 1750 ± 230 340 ± 63 69,850 ± 8040 Mild to moderate
Cerulein + 34.9 ± 5.2 197 ± 56 1770 ± 224 320 ± 25 ND 80,310 ± 15,230 Mild to moderate
MeSpd (5)

The rats received l-arginine (2.5g/kg i.p.) 24 hours before sacrifice or cerulein (50 μg/kg i.p. in seven hourly injections) before being sacrificed 1 hour after the last cerulein injection. MeSpd (50 mg/kg i.p.) was administered as two doses 20 hours and 4 hours before l-arginine or cerulein. The data are expressed as means ± SD. ND, not detectable. Numbers of animals per group are given in parentheses after each group definition. 

*

P < 0.05 and 

P < 0.01 as compared with untreated control animals. 

For definition of evaluation, see Materials and Methods.